Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the 1934 Act and is listed on The NASDAQ Capital Market (the “Nasdaq CM”) maintained by NASDAQ Stock Market LLC (“NASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the 1934 Act or removal from quotation of the Common Stock from the Nasdaq CM, nor has the Company received any notification that the SEC, NASDAQ or the Financial Industry Regulatory Authority, Inc. is contemplating terminating such registration or quotation.
Appears in 3 contracts
Samples: Purchase Agreement (Adamis Pharmaceuticals Corp), Purchase Agreement (Adamis Pharmaceuticals Corp), Purchase Agreement (Adamis Pharmaceuticals Corp)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the 1934 Act Act, and is listed on The NASDAQ Capital Market (the “Nasdaq CM”) maintained by NASDAQ Stock Market LLC (“NASDAQ”)National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the 1934 Act or removal from quotation of delisting the Common Stock from the Nasdaq CM, nor has the Company received any notification that the SEC, NASDAQ or the Financial Industry Regulatory Authority, Inc. is contemplating terminating such registration or quotationNational Market.
Appears in 2 contracts
Samples: Stock Purchase Agreement (Neurocrine Biosciences Inc), Stock Purchase Agreement (Neurocrine Biosciences Inc)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the 1934 Exchange Act and is listed on The NASDAQ Nasdaq Stock Market, Inc. Capital Market (the “Nasdaq CM”) maintained by NASDAQ Stock Market LLC (“NASDAQCapital Market”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the 1934 Exchange Act or removal from quotation of de-listing the Common Stock from the Nasdaq CMCapital Market, nor has the Company received any notification that the SEC, NASDAQ SEC or the Financial Industry Regulatory AuthorityNational Association of Securities Dealers, Inc. (the “NASD”) is contemplating terminating such registration or quotationlisting.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Solexa, Inc.), Securities Purchase Agreement (Solexa, Inc.)
Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the 1934 Exchange Act and is listed on The NASDAQ Capital Nasdaq Stock Market, Inc. National Market (the “Nasdaq CM”) maintained by "NASDAQ Stock Market LLC (“NASDAQ”NATIONAL MARKET"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the 1934 Exchange Act or removal from quotation of de-listing the Common Stock from the Nasdaq CMNational Market, nor has the Company received any notification that the SEC, NASDAQ SEC or the Financial Industry Regulatory AuthorityNational Association of Securities Dealers, Inc. (the "NASD") is currently contemplating terminating such registration or quotationlisting.
Appears in 1 contract
Samples: Stock and Warrant Purchase Agreement (Acusphere Inc)
Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g) of the 1934 Exchange Act and is listed on The NASDAQ Capital Market (the “Nasdaq CM”) maintained by NASDAQ Stock Market LLC (“NASDAQ”)Nasdaq, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the 1934 Exchange Act or removal from quotation of delisting the Common Stock from Nasdaq. The Company has not been notified by Nasdaq of any action or potential action by Nasdaq or of any violation of any Nasdaq Rules that could result in the Nasdaq CM, nor has delisting of the Company received any notification that the SEC, NASDAQ or the Financial Industry Regulatory Authority, Inc. is contemplating terminating such registration or quotationCompany’s Common Stock from Nasdaq.
Appears in 1 contract
Samples: Common Stock and Warrant Purchase Agreement (Rigel Pharmaceuticals Inc)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g12(b) of the 1934 Act and is listed on The NASDAQ the Nasdaq Capital Market (the “Nasdaq CM”) maintained by NASDAQ Stock Market LLC (“NASDAQNasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the 1934 Act or removal from quotation of the Common Stock from the Nasdaq CM, nor has the Company not received any notification that the SECCommission, NASDAQ the Nasdaq or the Financial Industry Regulatory Authority, Inc. is contemplating terminating such registration or quotationlisting.
Appears in 1 contract